US Patent Issued to INTRA-CELLULAR THERAPIES on Jan. 27 for "Methods of treatment comprising administering lumateperone mono-tosylate capsules" (California, New Jersey Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,355, issued on Jan. 27, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).

"Methods of treatment comprising administering lumateperone mono-tosylate capsules" was invented by Peng Li (New Milford, N.J.) and Robert Davis (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to pharmaceutical capsules comprising lumateperone, in free, or pharmaceutically acceptable salt form, optionally in combination with one or more additional therapeutic agents, processes for manufacture thereof and methods of use in the treatment or prophylaxis of disease."

The patent was filed on Sept. 29, 2023, under Application...